Immutep Limited carries a market capitalization of 58.85M, placing it among publicly traded companies globally.
| Market Cap | 58.85M |
| Enterprise Value | N/A |
Immutep Limited maintains a current ratio of 37.11, meaning it holds 37.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 37.11 |
| Quick Ratio | 36.21 |
| Debt / Equity | 1.82 |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Immutep Limited's stock has declined approximately -76.51176% over the past 52 weeks. The 50-day moving average sits at 0.42, while the 200-day moving average is 1.54.
| Beta (5Y) | N/A |
| 52-Week Price Change | -76.51176% |
| 50-Day Moving Average | 0.42 |
| 200-Day Moving Average | 1.54 |
| Average Volume (20 Days) | N/A |
| Operating Cash Flow | N/A |
| Capital Expenditures | -286,284.00 |
| Free Cash Flow | -286,284.00 |
| FCF Per Share | N/A |
Immutep Limited's most recent stock split took place on November 7, 2019 with a 10:1 split ratio.
| Last Split Date | 11/7/2019 |
| Split Ratio | 10:1 |
Immutep Limited posts an Altman Z-Score of -3.77, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -3.77 |